Effectiveness and Safety of Pharmacopuncture Treatment for Rotator Cuff Disease: Assessor-blinded, Pragmatic Randomized Controlled, Pilot Trial

Korea Institute of Oriental Medicine0 个研究点目标入组 40 人开始时间: 待定最近更新: 2022年11月28日

适应症

试验速览

暂无简介。

•1) 19-75 years old
•2) Those diagnosed with rotator cuff disease by other medical institutions or this researcher
•3) Visual Analogue Scale(VAS) of shoulder pain is more than 40mm
•4) Those who voluntarily decide to participate and consent in writing after hearing a sufficient explanation of the research purpose and process

•1) Participants who had undergone shoulder surgery within 3 months
•2) Participants who diagnosed with specific serious disease that may cause shoulder pain(bone metastasis of tumor, vertebral fracture, etc.)
•3) Participants who are scheduled for shoulder surgery within the study period
•4) Participants who have underlying disease (stroke, myocardial infarction, kidney disease, severe diabetes, dementia, epilepsy, severe hemorrhagic disease, etc.) that may interfere with treatment effect or interpretation of results
•5) Participants taking steroid, immunosuppressant, psychotropic medication, or taking other drugs within the last 3 months that may affect outcomes
•6) Participants with severe abnormalities in blood tests (AST or ALT is 3 times the upper limit of normal range, blood creatinine is 2 times the upper limit of normal range, etc.)
•7) Participants who took NSAIDs or pharmacopuncture, acupuncture, physical therapy within 1 week
•8) Pregnant, planning to get pregnant or lactating women
•9) Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial during follow up period of this trial
•10) Participants who are difficult to participate in the trial according to investigator's decision

发起方